Displaying 781 - 800 of 1017 results
Dr. Kaplan Receives GPP Outstanding Mentor Award
https://www.niams.nih.gov/labs/dr-kaplan-receives-gpp-outstanding-mentor-award
We are delighted to announce that Mariana Kaplan, M.D., Deputy Scientific Director of NIAMS and Chief of the Systemic Autoimmunity Branch, has received a 2021 Graduate Partnership Program Outstanding Mentor Award. This award recognizes outstanding mentors for their leadership and dedication to their graduate students.
Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Initiative Research Opportunity Announcements (ROAs)
This notice is to make you aware that NIH has published two Research Opportunity Announcements (ROAs) as part of its new Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) initiative. NIH is soliciting proposals for research that will improve understanding of and contribute to strategies to prevent and treat post-acute manifestations of
NIAMS Alum Appointed Chairman of Rheumatology and Clinical Immunology at Kyoto University
The NIAMS congratulates Professor Akio Morinobu on his appointment as Chairman of Rheumatology and Clinical Immunology at Kyoto University, Japan.
NIAMS’ John O’Shea Awarded 2021 Harrington Prize for Innovation in Medicine
For his groundbreaking work in immunology, John J. O’Shea, M.D., will receive the eighth annual Harrington Prize for Innovation in Medicine.
How to Manage Low Back Pain Before it Gets Worse
https://www.niams.nih.gov/how-manage-low-back-pain-it-gets-worse
Skin 101: Identifying common conditions
https://www.niams.nih.gov/skin-101-identifying-common-conditions
Advantage, Wozniacki: Tennis star on taking charge of life with RA
https://www.niams.nih.gov/advantage-wozniacki-tennis-star-taking-charge-life-ra
Dr. Sarfaraz Hasni Receives 2021 Coleman Research Innovation Award
We are delighted to announce that Sarfaraz Hasni, M.D., Director of the NIAMS Lupus Clinical Trials Unit, has received the 2021 William G. Coleman Jr., Ph.D., Minority Health and Health Disparities Research Innovation Award.
Study finds link between red hair and pain threshold
https://www.niams.nih.gov/study-finds-link-between-red-hair-and-pain-threshold
Pankaj Sharma, Ph.D.
https://www.niams.nih.gov/about/directory/pankaj-sharma-phd
Dr. Sharma is a postdoctoral fellow in the Pediatric Translational Research Branch at the NIAMS. His research focuses on identifying genetic variations and determining molecular mechanisms associated with human diseases.
Childhood Arthritis: When Joint Pain Affects Kids
https://www.niams.nih.gov/childhood-arthritis-when-joint-pain-affects-kids
A Ray of Hope for a Rare and Deadly Skin Cancer
https://www.niams.nih.gov/ray-hope-rare-and-deadly-skin-cancer
Postbac Poster Day Showcases Young Scientific Talent
https://www.niams.nih.gov/postbac-poster-day-showcases-young-scientific-talent
Promoting a Basic Understanding of Chemical Threats to Skin
Developing medical countermeasures to protect civilians against intentional and accidental toxic chemical exposure that can lead to mass casualties is a major goal of the biodefense program at NIH. More specifically, this goal is executed by the Chemical Countermeasures Research Program (CCRP) administered by NIAID and executed in partnership with several other ICs across the NIH, including NIAMS.
FY 2022 Congressional Justification
https://www.niams.nih.gov/about/budget/fy2022/congressional-justification
Weight loss and exercise to improve rheumatoid arthritis cardiovascular risk
Clinical Trials in the Spotlight Main Page The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) supports a range of clinical trials studying new and existing interventions for prevention and treatment of arthritis, musculoskeletal, and skin diseases. Investigators supported by the NIAMS need your help finding individuals to
Living With Scoliosis
https://www.niams.nih.gov/living-scoliosis
An NIH Health Capsule article. Scoliosis is a disease that causes the spine to curve. It can result in an abnormal s-shaped or c-shaped curve. Anyone can get scoliosis. But it’s most common in children age 11 and older.